Edgewise Therapeutics Stock (NASDAQ: EWTX) stock price, news, charts, stock research, profile.
Open | $25.75 |
Close | - |
Volume / Avg. | 6.24M / 967.14K |
Day Range | $24.84 - $28.20 |
52 Wk Range | 5.12 - 23.50 |
Market Cap | $2.65B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 78 |
Short Interest | 12.19% |
Days to Cover | 10.51 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Edgewise Therapeutics (NASDAQ:EWTX) through any online brokerage.
Other companies in Edgewise Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP) and Neumora Therapeutics (NASDAQ:NMRA).
Edgewise Therapeutics has a consensus price target of $28.86.
The stock price for Edgewise Therapeutics (NASDAQ: EWTX) is $28.2487 last updated September 19, 2024 at 11:05 AM EDT.
There are no upcoming dividends for Edgewise Therapeutics.
Edgewise Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Edgewise Therapeutics.
Edgewise Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.